(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






887 Result: Intel

Intel to Acquire Mobileye

March 13th, 2017

Combining Technology and Talent to Accelerate the Future of Autonomous Driving NEWS HIGHLIGHTS * Brings together Mobileye’s leading computer vision expertise with Intel’s high-performance computing and connectivity expertise to crea. Read more

Bombardier Wins Contract to Provide 70 FLEXITY Trams to Zurich

March 03rd, 2017

* Contract includes an option for 70 additional vehicles * Modern FLEXITY trams feature 20% more passenger capacity than vehicles currently in use in Zurich Berlin, Germany / CRWE PRESS RELEASE / March 1, 2017 - Rail technology leader Bombardier . Read more

Sierra Wireless selected by PrecisionHawk to enable drone safety and traffic management

February 23rd, 2017

Sierra Wireless and PrecisionHawk will demonstrate the LTE-enabled LATAS Platform at Mobile World Congress 2017 Vancouver, B.C. / CRWE PRESS RELEASE / February 23, 2017 - Sierra Wireless (NASDAQ: SWIR) (TSX: SW), a leading provider of fully integr. Read more

Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook

February 13th, 2017

HAIFA, Israel / CRWE PRESS RELEASE / February 13, 2017 - Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments for . Read more

Volkswagen prefers Sierra Wireless to enable next-generation connected vehicles with 4G LTE embedded modules

February 09th, 2017

Sierra Wireless AirPrime® AR Series embedded modules and Legato® platform will enable Car-Net connectivity for Volkswagen automobiles beginning in 2018 Vancouver, B.C. / CRWE PRESS RELEASE / February 09, 2017 - Sierra Wireless (NASDAQ: SWI. Read more

Kitov Provides Further Update on Formal Investigation by Israeli Securities Authority

February 09th, 2017

Tel Aviv, Israel / CRWE PRESS RELEASE / February 9, 2017 - Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, in response to requests made by the NASDAQ Stock Market, today provided a further upda. Read more

Qualcomm Comments on Apple Complaint

January 22nd, 2017

SAN DIEGO / CRWE PRESS RELEASE / Jan. 20, 2017 - “While we are still in the process of reviewing the complaint in detail, it is quite clear that Apple’s claims are baseless. Apple has intentionally mischaracterized our agreements and nego. Read more

Pluristem Announces Bought Deal Offering

January 19th, 2017

Haifa, Israel / CRWE PRESS RELEASE / January 19, 2017 - Pluristem Therapeutics Inc. (NASDAQCM: PSTI, TASE: PLTR) announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC, under which the underwriter has agree. Read more

Pluristem Receives Clearance from Germany to Initiate its Multinational Phase III Trial in Critical Limb Ischemia Targeting Early Conditional Marketing Approval

January 17th, 2017

* PLX-PAD cells could potentially obtain early conditional marketing approval in Europe via the Adaptive Pathways pilot project based on positive interim efficacy data from first 125 patients * This approval joins those from the U.S. FDA and U.K. fo. Read more

Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen

January 17th, 2017

* Biogen will pay Forward a non-refundable cash fee of $1.25 billion * Forward may be eligible to receive royalties of 10% of net sales of Tecfidera beginning in 2021, and of 20% of net sales beginning in 2029, depending on the outcome of certain . Read more

Pluristem Completes Patient Enrollment in a Large Multinational Phase II Trial in Intermittent Claudication

January 12th, 2017

* Top line results from the 172-patient trial to be reported in early 2018 * Data to support Pluristem’s planned Biologics License Application for marketing approval of PLX-PAD in the U.S. and Europe * 14 million people in the U.S. are treate. Read more

Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients

January 06th, 2017

LOS ANGELES, Calif. / CRWE PRESS RELEASE / Jan. 6, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, has expanded the fourth cohort from its Phase II SUMMIT clinical trial of its lead drug candidate PB272 (neratinib) as a s. Read more

BlackBerry QNX Launches its Most Advanced and Secure Embedded Software Platform for Autonomous Drive and Connected Cars

January 04th, 2017

LAS VEGAS, NEVADA / CRWE PRESS RELEASE / Jan. 4, 2017 - International CES 2017, LVCC North Hall, Booth 7029 - BlackBerry Limited (NASDAQ:BBRY) (TSX:BB) today announced its most advanced and secure embedded operating system (OS) for the automotive ind. Read more

Pluristem and New York Blood Center to Collaborate in Evaluating PLX-R18 as an Adjuvant Therapy to Umbilical Cord Blood Transplantation, Winning $900,000 Funding From BIRD

December 27th, 2016

* Prior research has suggested that PLX-R18 helps cord blood cells to engraft more rapidly and effectively * Grant of $900,000 from Israel-U.S. Binational Industrial Research and Development Foundation (BIRD) to fund the research * Constitutes a 3r. Read more

Bombardier Announces 2017 Guidance, Targeting Strong Earnings Growth and FCF Improvement

December 14th, 2016

* Targets EBIT growth before special items(1) of approximately 50%, to $530 million - $630 million * Anticipates year-over-year free cash flow usage(1) improvement by approximately $400 million, to $750 million - $1.0 billion * Expects low sing. Read more

Load More Content